2.01.38 Transesophogeal Endoscopic Therapies for Gastroesophageal Reflux Disease

2.01.38 Transesophogeal Endoscopic Therapies for Gastroesophageal Reflux Disease

Coding CPT 43201 Esophagoscopy, flexible, transoral; with directed submucosal injection(s), any substance 43210 Esophagogastroduodenoscopy, flexible, transoral; with esophagogastric fundoplasty, partial or complete, includes duodenoscopy when performed 43236 Esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance 43257 Esophagogastroduodenoscopy, fl...

Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease

Is Prone Position One of the Symptoms of Childhood Gastroesophageal Reflux Disease?

Background & Aims: The aim of the present study was to find whether prone position is one of the symptoms of childhood gastroesophageal reflux disease or not. Method: In this prospective case-control study, 200 children with gastroesophgeal reflux disease (case group) and 210 healthy children (control group) were studied between 21 march 2009 and 21 march 2011. Data gathering was performed by a...

Transesophageal endoscopic treatments for gastroesophageal reflux disease.

OVERVIEW Transesophageal endoscopic therapies are being developed for the treatment of gastroesophageal reflux disease (GERD). A variety of procedures are being evaluated, including transesophageal (or transoral) incisionless fundoplication (TIF), application of radiofrequency (RF) energy, and injection/implantation of prosthetic devices or bulking agents. Note: This policy does not pertain to ...

A Review of New Surgical and Endoscopic Therapies for Gastroesophageal Reflux Disease.

Treatment of gastroesophageal reflux disease in the United States today is binary, with the majority of patients with gastroesophageal reflux disease being treated with antisecre-tory medications and a minority of patients, typically those with volume regurgitation, undergoing Nissen fundoplication. However, there has been increasing dissatisfaction with proton pump inhibitor therapy among a si...